Genmab — Januar 2020
-
Amerikansk biotech viser nu kæmpe svaghed, trendvending?: https://www.proinvestor.com/investornyt/653212/amerikansk-biotech-viser-nu-kaempe-svaghed-trendvending
-
The Lancet! - DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant
B cells in preclinical models and provides opportunities for subcutaneous
dosing -
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(19)30840-0/fulltext -
God morgen.

-
-
"Only one dose of daratumumab can decrease the amyloidogenic precursor immunoglobulin light chain protein rapidly and can lead to reversal of organ dysfunction in patients with AL amyloidosis" https://www.news-medical.net/news/20200127/Daratumumab-proves-effective-in-patients-with-relapsed-AL-amyloidosis.aspx
-
God morgen

-
God morgen.

-
God morgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind